Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Patient	O
recorded	O
as	O
having	O
No	O
Known	O
Allergies	O
to	O
Drugs	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Chest	O
Pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none.	O
History	O
of	O
Present	O
Illness:	O
Mrs.	O
___	O
is	O
a	O
___	O
year	O
old	O
female	O
ESRD	O
on	O
___	O
HD-Sa	O
UF,	O
CHF	O
(diastolic	O
dysfunction,	O
LVEF	O
>	O
55%),	O
COPD,	O
DM2,	O
s/p	O
bilat	O
BKA	O
brought	O
to	O
the	O
ED	O
today	O
after	O
experiencing	O
chest	O
pain.	O
Per	O
patient,	O
she	O
was	O
at	O
her	O
scheduled	O
HD	O
today	O
when	O
she	O
started	O
to	O
have	O
some	O
jaw	O
pain	O
and	O
both	O
of	O
her	O
hands	O
started	O
feeling	O
heavy.	O
She	O
associates	O
these	O
symptoms	O
with	O
being	O
hypotensive,	O
which	O
she	O
was.	O
She	O
then	O
developed	O
chest	O
pain	O
that	O
continued	O
until	O
she	O
reached	O
her	O
house.	O
She	O
did	O
not	O
alert	O
the	O
dialysis	O
center	O
to	O
her	O
symptoms.	O
At	O
home,	O
she	O
continued	O
to	O
have	O
chest	O
pain	O
after	O
resting	O
and	O
decided	O
to	O
call	O
___.	O
When	O
the	O
ambulance	O
arrived,	O
patient	O
states	O
that	O
her	O
chest	O
pain	O
stopped	O
and	O
she	O
felt	O
much	O
better.	O
There	O
were	O
no	O
other	O
associated	O
symptoms.	O
She	O
denied	O
nausea,	O
vomitting,	O
shortness	O
of	O
breath	O
out	O
of	O
ordinary	O
(she	O
uses	O
3L	O
O2	O
at	O
home	O
for	O
ambulation),	O
headache,	O
or	O
loss	O
of	O
conciousness.	O
.	O
Patient	O
was	O
recently	O
admitted	O
for	O
chest	O
pain	O
after	O
hypotensive	O
episode	O
at	O
HD.	O
She	O
was	O
discharged	O
on	O
___	O
after	O
MI	O
rule	O
out.	O
During	O
this	O
episode,	O
she	O
was	O
treated	O
in	O
the	O
ED	O
with	O
IV	O
boluses,	O
with	O
good	O
response	O
in	O
her	O
BP.	O
Lisinopril	O
was	O
decreased	O
to	O
5	O
mg	O
PO	O
qday.	O
.	O
In	O
the	O
ED,	O
initial	O
vs	O
were:	O
T	O
99.2	O
P	O
___	O
BP	O
110/51	O
R	O
16	O
O2	O
sat.	O
100RA	O
Patient	O
was	O
admitted	O
for	O
MI	O
rule-out	O
and	O
possible	O
stress	O
test	O
requested	O
by	O
PCP.	O
.	O
On	O
the	O
floor,	O
patient	O
was	O
in	O
NAD.	O
Past	O
Medical	O
History:	O
-	O
ESRD	O
on	O
___	O
HD	O
since	O
___,	O
has	O
1.5h	O
UF	O
session	O
on	O
___,	O
presumed	O
due	O
to	O
DM2	O
-	O
COPD	O
-	O
home	O
O2,	O
___	O
-	O
DM2	O
on	O
insulin	O
-	O
CHF	O
with	O
diastolic	O
dysfunction,	O
(LVEF	O
55%,	O
small	O
LV	O
chamber,	O
LVH)	O
-	O
paroxysmal	O
afib,	O
s/p	O
failed	O
ablation,	O
on	O
warfarin	O
-	O
HTN	O
c/b	O
LVH,	O
LVOT	O
-	O
HLP	O
-	O
PVD	O
s/p	O
bilateral	O
BKAs	O
-	O
glaucoma,	B-Visual_impairment
left	O
eye	B-Visual_impairment
blindness	B-Visual_impairment
-	O
GERD	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
with	O
DM2,	O
Mother	O
deceased	O
of	O
stroke.	O
Siblings	O
died	O
of	O
cancer	O
(unknown	O
type),	O
stroke	O
and	O
brain	O
cancer.	O
Seven	O
health	O
children.	O
Extended	O
family	O
history	O
positive	O
for	O
CAD,	O
cancer	O
and	O
DM.	O
Physical	O
Exam:	O
Vitals:	O
T:	O
97.9	O
BP:	O
112/52	O
P:	O
76	O
R:	O
18	O
O2:100	O
2L	O
NC	O
General:	O
Alert,	O
oriented,	B-Delirium
no	O
acute	O
distress	O
HEENT:	O
Sclera	O
anicteric,	O
MMM,	O
oropharynx	O
clear,	O
eye	O
movements	O
coordinated,	O
blind	B-Visual_impairment
in	O
left	O
eye.	B-Visual_impairment
no	O
dentition,	O
dentures	O
not	O
in.	O
Neck:	O
supple,	O
no	O
LAD,	O
no	O
thyromegally	O
Lungs:	O
Clear	O
to	O
auscultation	O
bilaterally,	O
no	O
wheezes,	O
rales,	O
rhonchi	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
___	O
systolic	O
murmur	O
radiating	O
to	O
carotids,	O
no	O
rubs	O
or	O
gallops	O
Abdomen:	O
soft,	O
non-tender,	O
non-distended,	O
bowel	O
sounds	O
present,	O
no	O
rebound	O
tenderness	O
or	O
guarding,	O
no	O
organomegaly	O
Ext:	O
Warm,	O
well	O
perfused,	O
2+	O
pulses	O
radial	O
pulses.	O
Bilateral	O
BKA,	O
callous	O
on	O
Right	O
amputation	O
site.	O
Failed	O
fistula	O
noted	O
on	O
left	O
upper	O
arm.	O
Skin:	O
no	O
rashes,	O
bruises	O
or	O
ulcers	B-Pressure_injury
noted.	O
Neuro:	O
CN	O
II-XII	O
intact,	O
strength	O
___	O
in	O
all	O
extremities,	O
sensation	O
intact	O
bialterally	O
in	O
upper	O
extremities,	O
no	O
dysdidochokinesis.	O
Pertinent	O
Results:	O
___	O
01:20PM	O
BLOOD	O
WBC-8.6	O
RBC-3.15*	O
Hgb-9.4*	O
Hct-31.0*	O
MCV-98	O
MCH-29.8	O
MCHC-30.3*	O
RDW-18.8*	O
Plt	O
___	O
___	O
05:50AM	O
BLOOD	O
WBC-7.7	O
RBC-3.24*	O
Hgb-9.6*	O
Hct-32.4*	O
MCV-100*	O
MCH-29.7	O
MCHC-29.7*	O
RDW-18.5*	O
Plt	O
___	O
___	O
01:20PM	O
BLOOD	O
Glucose-113*	O
UreaN-10	O
Creat-2.8*#	O
Na-141	O
K-3.8	O
Cl-100	O
HCO3-31	O
AnGap-14	O
___	O
05:50AM	O
BLOOD	O
Glucose-87	O
UreaN-22*	O
Creat-4.5*#	O
Na-141	O
K-4.5	O
Cl-99	O
HCO3-32	O
AnGap-15	O
___	O
01:20PM	O
BLOOD	O
cTropnT-0.10*	O
___	O
07:25PM	O
BLOOD	O
CK-MB-NotDone	O
cTropnT-0.18*	O
___	O
03:31AM	O
BLOOD	O
CK-MB-NotDone	O
cTropnT-0.21*	O
___	O
01:20PM	O
BLOOD	O
CK(CPK)-42	O
___	O
07:25PM	O
BLOOD	O
CK(CPK)-51	O
___	O
03:31AM	O
BLOOD	O
CK(CPK)-41	O
___	O
05:50AM	O
BLOOD	O
Calcium-9.4	O
Phos-4.3	O
Mg-2.1	O
Brief	O
Hospital	O
Course:	O
This	O
is	O
a	O
___	O
year	O
old	O
female	O
ESRD	O
on	O
___	O
HD-Sa	O
UF,	O
CHF	O
(diastolic	O
dysfunction,	O
LVEF	O
>	O
55%),	O
COPD,	O
DM2,	O
s/p	O
bilat	O
BKA	O
admitted	O
___	O
chest	O
pain.	O
.	O
#	O
Chest	O
Pain	O
-	O
Patient	O
was	O
brought	O
by	O
ambulance	O
to	O
the	O
ED	O
for	O
complaint	O
of	O
chest	O
pain.	O
At	O
time	O
of	O
presentation,	O
she	O
was	O
chest	O
pain	O
free	O
with	O
no	O
complaints.	O
EKG	O
was	O
done	O
in	O
the	O
ED	O
and	O
showed	O
no	O
changes	O
from	O
prevoius	O
EKG	O
on	O
___.	O
Cardiac	O
Enzymes	O
were	O
drawn	O
which	O
showed	O
toponin	O
=	O
0.10.	O
Patient	O
was	O
admitted	O
to	O
the	O
floor.	O
On	O
the	O
floor,	O
she	O
was	O
placed	O
on	O
high	O
dose	O
aspirin	O
and	O
continued	O
on	O
all	O
of	O
her	O
home	O
medications.	O
Cardiac	O
enzymes	O
were	O
drawn	O
at	O
q8	O
hour	O
intervals.	O
Troponin	O
increased	O
to	O
0.18	O
->	O
0.21.	O
CK	O
trended	O
from	O
42	O
->	O
51	O
->	O
41.	O
The	O
patient	O
was	O
arrnaged	O
to	O
have	O
UF	O
done	O
on	O
___	O
per	O
her	O
___-Sa	O
dialysis	O
schedule.	O
After	O
dialysis,	O
repeat	O
EKG	O
showed	O
no	O
changes.	O
The	O
patient	O
expressed	O
an	O
interest	O
to	O
go	O
home	O
and	O
in	O
light	O
of	O
ESRD,	O
troponin	O
rise	O
was	O
less	O
concerning,	O
especially	O
since	O
CK	O
was	O
normal	O
and	O
with	O
history	O
of	O
normal	O
cardiac	O
cath	O
in	O
___.	O
The	O
case	O
was	O
discussed	O
with	O
the	O
___	O
attending	O
on	O
call	O
and	O
it	O
was	O
felt	O
that	O
further	O
work-up	O
for	O
this	O
patient	O
would	O
best	O
be	O
done	O
as	O
an	O
outpatient.	O
Patient	O
was	O
discharged	O
home,	O
with	O
no	O
chest	O
pain	O
and	O
instructed	O
to	O
follow-up	O
at	O
her	O
previously	O
arranged	O
appointment	O
with	O
Dr.	O
___.	O
.	O
#	O
ESRD	O
-	O
Patient	O
with	O
ESRD,	O
likely	O
___	O
DM2,	O
on	O
HD	O
MWF	O
with	O
UF	O
on	O
Sa.	O
Patient	O
was	O
placed	O
on	O
renal	O
diet,	O
phosphate	O
binder	O
ocntinued	O
and	O
had	O
volume	O
taken	O
off	O
the	O
morning	O
of	O
discharge.	O
She	O
was	O
asymptommatic	O
during	O
dialysis	O
with	O
stable	O
hemodynamics.	O
.	O
#	O
Hypertension	O
-	O
Patient	O
with	O
history	O
of	O
hypertension	O
with	O
complication	O
of	O
LVH	O
and	O
LVOT	O
obstruction.	O
Continued	O
Verapamil,	O
Metoprolol,	O
Lisinopril	O
with	O
holding	O
parameters.	O
.	O
#	O
COPD	O
-	O
history	O
of	O
COPD,	O
on	O
home	O
O2.	O
Continued	O
oxygen	O
as	O
needed.	O
The	O
morning	O
of	O
discharge,	O
she	O
was	O
not	O
requiring	O
any	O
supplemental	O
oxygen.	O
Spiriva	O
and	O
albuterol	O
were	O
continued.	O
.	O
#	O
Paroxysmal	O
A-fib	O
-	O
On	O
warfarin,	O
INR	O
2.6	O
on	O
admission	O
which	O
is	O
therapeutic.	O
EKG	O
with	O
no	O
sign	O
of	O
Afib	O
on	O
admission.	O
Continued	O
Warfarin	O
at	O
3	O
mg	O
PO	O
qday.	O
INR	O
therapeutic	O
on	O
day	O
of	O
discharge.	O
Patient	O
was	O
informed	O
to	O
have	O
INR	O
checked	O
at	O
dialysis,	O
per	O
routine,	O
on	O
___.	O
An	O
email	O
was	O
sent	O
to	O
nurse	O
at	O
___	O
___	O
to	O
alert	O
her	O
of	O
patients	O
discharge	O
coumadin	O
dosing.	O
.	O
#	O
Diastolic	O
Congestive	O
Heart	O
Failure	O
-	O
LVEF	O
>	O
55	O
%,	O
no	O
signs	O
of	O
fluid	O
overload	O
on	O
exam	O
or	O
CXR.	O
Recieved	O
HD	O
to	O
only	O
take	O
fluid	O
off	O
on	O
the	O
morning	O
of	O
discharge.	O
.	O
#	O
DM	O
-	O
history	O
of	O
type	O
2	O
DM,	O
on	O
NPH	O
4	O
units	O
qam	O
and	O
qpm.	O
Decreased	O
NPH	O
to	O
2	O
units	O
qam	O
and	O
qpm	O
with	O
Humalog	O
Insulin	O
SS.	O
Glucose	O
was	O
well	O
controlled	O
and	O
patient	O
was	O
discharged	O
on	O
home	O
regimen	O
of	O
NPH.	O
Medications	O
on	O
Admission:	O
1.	O
Verapamil	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q8H	O
2.	O
Aspirin	O
81	O
mg	O
Tablet	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
3.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
as	O
needed	O
for	O
constipation.	B-Constipation
4.	O
Senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day)	O
as	O
needed	O
for	O
constipation.	B-Constipation
5.	O
Pantoprazole	O
40	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
Q24H	O
(every	O
24	O
hours).	O
6.	O
Calcium	O
Acetate	O
667	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
TID	O
W/MEALS	O
(3	O
TIMES	O
A	O
DAY	O
WITH	O
MEALS).	O
7.	O
Novolin	O
N	O
PenFill	O
100	O
unit/mL	O
Cartridge	O
Sig:	O
4	O
units	O
in	O
the	O
morning.	O
Subcutaneous	O
4	O
units	O
at	O
evening.	O
8.	O
Fluticasone	O
50	O
mcg/Actuation	O
Spray,	O
Suspension	O
Sig:	O
One	O
(1)	O
Spray	O
Nasal	O
BID	O
(2	O
times	O
a	O
day).	O
9.	O
Latanoprost	O
0.005	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
HS	O
(at	O
bedtime).	O
10.	O
Dorzolamide-Timolol	O
___	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
BID	O
(2	O
times	O
a	O
day):	O
in	O
L	O
eye.	O
11.	O
Tiotropium	O
Bromide	O
18	O
mcg	O
Capsule,	O
w/Inhalation	O
Device	O
Sig:	O
One	O
(1)	O
Cap	O
Inhalation	O
DAILY	O
(Daily).	O
12.	O
Simvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
13.	O
Brimonidine	O
0.15	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
BID	O
(2	O
times	O
a	O
day):	O
in	O
R	O
eye.	O
14.	O
B	O
Complex-Vitamin	O
C-Folic	O
Acid	O
1	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Cap	O
PO	O
DAILY	O
(Daily).	O
15.	O
Amiodarone	O
200	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
16.	O
Warfarin	O
1	O
mg	O
Tablet	O
Sig:	O
Three	O
(3)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
17.	O
Lisinopril	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
at	O
bedtime.	O
Disp:*30	O
Tablet(s)*	O
Refills:*0*	O
18.	O
Albuterol	O
Sulfate	O
90	O
mcg/Actuation	O
HFA	O
Aerosol	O
Inhaler	O
Sig:	O
One	O
(1)	O
puff	O
Inhalation	O
every	O
six	O
(6)	O
hours	O
as	O
needed	O
for	O
shortness	O
of	O
breath	O
or	O
wheezing.	O
19.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
20.	O
Ammonium	O
Lactate	O
12	O
%	O
Cream	O
Sig:	O
One	O
(1)	O
Topical	O
once	O
a	O
day:	O
Use	O
on	O
arms	O
and	O
legs	O
daily.	O
21.	O
EMLA	O
2.5-2.5	O
%	O
Cream	O
Sig:	O
One	O
(1)	O
Topical	O
TIW:	O
TIW:	O
Apply	O
to	O
fistula	O
as	O
directed	O
pre-HD	O
TIW.	O
22.	O
Acetaminophen	O
650	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day	O
as	O
needed	O
for	O
pain:	O
for	O
headache.	O
23.	O
Folic	O
Acid	O
1	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
Discharge	O
Medications:	O
1.	O
Verapamil	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
every	O
eight	O
(8)	O
hours.	O
2.	O
Aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
once	O
a	O
day.	O
3.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
4.	O
Senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day)	O
as	O
needed	O
for	O
constipation.	B-Constipation
5.	O
Pantoprazole	O
40	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
once	O
a	O
day.	O
6.	O
Calcium	O
Acetate	O
667	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
TID	O
W/MEALS	O
(3	O
TIMES	O
A	O
DAY	O
WITH	O
MEALS).	O
7.	O
Novolin	O
N	O
PenFill	O
100	O
unit/mL	O
Cartridge	O
Sig:	O
Four	O
(4)	O
units	O
Subcutaneous	O
in	O
the	O
morning	O
and	O
at	O
night.	O
8.	O
Fluticasone	O
50	O
mcg/Actuation	O
Spray,	O
Suspension	O
Sig:	O
One	O
(1)	O
spray	O
Nasal	O
twice	O
a	O
day.	O
9.	O
Latanoprost	O
0.005	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
HS	O
(at	O
bedtime).	O
10.	O
Dorzolamide-Timolol	O
___	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
BID	O
(2	O
times	O
a	O
day).	O
11.	O
Tiotropium	O
Bromide	O
18	O
mcg	O
Capsule,	O
w/Inhalation	O
Device	O
Sig:	O
One	O
(1)	O
Cap	O
Inhalation	O
DAILY	O
(Daily).	O
12.	O
Simvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
HS	O
(at	O
bedtime).	O
13.	O
Brimonidine	O
0.15	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
BID	O
(2	O
times	O
a	O
day).	O
14.	O
B	O
Complex-Vitamin	O
C-Folic	O
Acid	O
1	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
once	O
a	O
day.	O
15.	O
Amiodarone	O
200	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
16.	O
Warfarin	O
1	O
mg	O
Tablet	O
Sig:	O
Three	O
(3)	O
Tablet	O
PO	O
once	O
a	O
day.	O
17.	O
Lisinopril	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
at	O
bedtime.	O
18.	O
Albuterol	O
Sulfate	O
90	O
mcg/Actuation	O
HFA	O
Aerosol	O
Inhaler	O
Sig:	O
One	O
(1)	O
puff	O
Inhalation	O
every	O
six	O
(6)	O
hours	O
as	O
needed	O
for	O
shortness	O
of	O
breath	O
or	O
wheezing.	O
19.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
twice	O
a	O
day.	O
20.	O
Ammonium	O
Lactate	O
12	O
%	O
Lotion	O
Sig:	O
One	O
(1)	O
topical	O
Topical	O
daily	O
():	O
Use	O
on	O
arms	O
and	O
legs	O
daily.	O
21.	O
EMLA	O
2.5-2.5	O
%	O
Cream	O
Sig:	O
One	O
(1)	O
Topical	O
Topical	O
three	O
times	O
a	O
week:	O
Apply	O
pre-dialysis	O
to	O
fistual	O
as	O
directed.	O
22.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily)	O
as	O
needed	O
for	O
pain.	O
23.	O
Folic	O
Acid	O
1	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary	O
Diagnosis:	O
1.	O
Chest	O
Pain	O
NOS	O
2.	O
ESRD	O
Secondary	O
Diagnosis:	O
1.	O
Hypertension	O
2.	O
COPD	O
3.	O
CHF,	O
diastolic	O
Discharge	O
Condition:	O
Stable,	O
no	O
chest	O
pain.	O
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
due	O
to	O
chest	O
pain	O
that	O
you	O
experienced	O
during	O
dialysis	O
on	O
___.	O
You	O
had	O
no	O
chest	O
pain	O
during	O
your	O
hospital	O
stay.	O
While	O
in	O
the	O
___	O
we	O
made	O
sure	O
that	O
you	O
were	O
not	O
having	O
a	O
heart	O
attack.	O
You	O
had	O
volume	O
pulled	O
off	O
at	O
dialysis	O
on	O
___	O
before	O
you	O
were	O
discharged.	O
Please	O
follow	O
up	O
with	O
your	O
PCP	O
on	O
___	O
at	O
10:45	O
as	O
listed	O
below.	O
Medication	O
Changes:	O
No	O
Changes	O
-	O
Please	O
take	O
all	O
home	O
medications	O
as	O
previously	O
prescribed	O
Weigh	O
yourself	O
every	O
morning,	O
call	O
MD	O
if	O
weight	O
>	O
3	O
lbs.	O
Adhere	O
to	O
2	O
gm	O
sodium	O
diet	O
If	O
you	O
experience	O
chest	O
pain,	O
shortness	O
of	O
breath,	O
fever	O
>	O
100.4,	O
loss	O
of	O
conciousness,	O
seizure	B-Seizures
or	O
tremors	O
or	O
any	O
other	O
symptoms	O
that	O
concern	O
you,	O
please	O
call	O
your	O
PCP	O
or	O
go	O
to	O
the	O
nearest	O
emergency	O
room	O
for	O
evaluation.	O
Followup	O
Instructions:	O
___	O

